In clinical settings, altered glycolysis can indicate underlying health issues. For example, in diabetic ketoacidosis (DKA), impaired glucose metabolism leads to the accumulation of ketone bodies. Additionally, certain cancers exhibit increased glycolytic activity, known as the Warburg effect, which can be targeted for therapeutic interventions.
